Tas-ox drug page Clinical trials

Trials with Tas-ox

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
41Planned patients

Showing 1–1 of 1

TAS-OX for Refractory Metastatic Colon Cancer
Finished Phase 1 41 patients NCT02848079

This study will examine the safety and effectiveness of oxaliplatin in combination with TAS-102 (TAS-OX) for treatment of patients with metastatic colorectal cancer whose cancer has progressed or recurred after FOLFOX chemotherapy.

United States Oct 2016 – Jun 2020 Interventional